Skip to content
10-Q

Quarterly Report

Luckwel Pharmaceuticals Inc.

0001493152-21-022174

← back to feed
Filed
Sep 8, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Jul 31, 2021 147.16M sh
Operating Cash Flow Q3 2021 · Dec 31, 2020 −$41.93K
Operating Cash Flow Q3 2021 · Dec 31, 2019 −$250.44K
Cash And Equivalents Q3 2021 · Dec 31, 2020 $3.12K
Cash And Equivalents Q3 2021 · Mar 31, 2020 $44
Stockholders Equity Q3 2021 · Dec 31, 2020 −$1.55M
Stockholders Equity Q3 2021 · Sep 30, 2020 −$1.47M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$1.33M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$1.18M
Stockholders Equity restated Q3 2021 · Sep 30, 2019 −$1.03M
Stockholders Equity Q3 2021 · Mar 31, 2019 −$791.82K
Total Liabilities Q3 2021 · Dec 31, 2020 $1.56M
Total Liabilities Q3 2021 · Mar 31, 2020 $1.35M
Total Assets Q3 2021 · Dec 31, 2020 $13.47K
Total Assets Q3 2021 · Mar 31, 2020 $17.21K
Sga Expense Q3 2021 · Dec 31, 2020 $78.98K
Sga Expense Q3 2021 · Dec 31, 2020 $220.21K
Sga Expense Q3 2021 · Dec 31, 2019 $134.05K
Sga Expense Q3 2021 · Dec 31, 2019 $385.95K
Net Income Q3 2021 · Dec 31, 2020 −$79.24K
Net Income Q3 2021 · Dec 31, 2020 −$220.95K
Net Income Q3 2021 · Dec 31, 2019 −$134.05K
Net Income Q3 2021 · Dec 31, 2019 −$385.95K